3rd Quarter - Report
INTERNATIONAL MYELOMA FOUNDATION for INTERNATIONAL MYELOMA FOUNDATION
Income
—
Expenses
$81,388
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 9747, (P.L. 118-83) the FY2025 Continuing Appropriations and Extensions Act: Cancer Research, Appropriations: Cancer Research, NIH, CDC, NCI, DoD, ARPA-H
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DOHENY | — |
Health Issues HCR
Access Issues, Cancer Drug Parity Act, Safe Step Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DOHENY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.